Wilmington, Delaware, Nov. 23, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s most recent industry analysis, the Global Dengue Vaccine Market value is estimated at US$ 0.6 billion in 2023 and is expected to rise at a strong CAGR of over 10.8% over the forecast period of 2023-2030.
Market Definition, Market Scope, and Report Overview
Dengue is a mosquito-borne viral infection that can cause a range of symptoms, from mild flu-like illness to severe and potentially life-threatening conditions. The dengue virus is primarily transmitted to humans through the bites of infected Aedes mosquitoes. Dengue is a significant public health concern, especially in tropical and subtropical regions where the Aedes mosquito is prevalent. Outbreaks of dengue can lead to a high burden of illness, hospitalizations, and mortality. A vaccine could help reduce the incidence and severity of dengue infections.
Vaccines are crucial tools in preventing the spread of infectious diseases. A dengue vaccine could be a key component in comprehensive public health strategies to control and prevent outbreaks.
According to a deep-dive market assessment by RationalStat, the global Dengue Vaccine market has been analyzed on the basis of market segments, including type, distribution channel and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.
- Market intelligence for the global Dengue Vaccine market covers market sizes on the basis of market value (US$/EUR Million) and volume (Units) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
- In addition, the long-term sector and products/services 10-year outlook and its implications on the global Dengue Vaccine market. It also includes the industry's current state – Production Levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.
Request A Customization- https://store.rationalstat.com/store/global-dengue-vaccine-market/#tab-ux_global_tab
Global Dengue Vaccine Market: Segmental and Market Share Analysis
- On the basis of distribution channel, hospital pharmacy is expected to dominate the global dengue vaccine market. Most of the patients trusted the hospital treatment and needed to admit in the hospital during the viral fever.
Report Synopsis
| Report Metrics | Details |
| Base Year | 2023 |
| Forecast Period | 2023-2030 |
| Base Year Market Size | US$ 0.6 billion |
| Market Size Forecast | US$ 1.3 billion |
| Growth Rate | 10.8% |
| Dominant Segment | Hospital Pharmacy |
| Dominant Region | Asia Pacific |
| Key Market Drivers |
|
| Companies Profiled |
|
Explore more about this report- https://store.rationalstat.com/store/global-dengue-vaccine-market/#tab-ux_global_tab
Competition Analysis and Market Structure
Some leading players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & and acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global dengue vaccine market include.
- In March 2021, Takeda Pharmaceutical Company Limited stated that the European Medicines Agency (EMA) approved its TAK-003 dengue vaccine candidate for preventing outbreaks in people aged 4 to 60.
Some of the prominent players and suppliers operating and contributing significantly to the global dengue vaccine market growth include Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, GSK plc, Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited, BIO-MED, Intercept Pharmaceuticals, and Emcure Pharmaceuticals Limited, among others.
Get A Free Sample- https://store.rationalstat.com/store/global-dengue-vaccine-market/#tab-ux_global_tab
RationalStat has segmented the global dengue vaccine market based on type, distribution channel and region
- Global Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Type
- Live Attenuated Vaccine
- Chimeric Live Attenuated Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Nucleic Acid Based Vaccine
- Global Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by distribution channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Global Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Region
- North America Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- US
- Canada
- Latin America Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Brazil
- Mexico
- Rest of Latin America
- Western Europe Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Russia
- Poland
- Hungary
- Other CIS Countries
- Rest of Eastern Europe
- Asia Pacific Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Indonesia
- Thailand
- Philippines
- Vietnam
- Malaysia
- Rest of ASEAN
- Rest of Asia Pacific
- Middle East & Africa Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- GCC
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of the GCC
- South Africa
- Nigeria
- Turkey
- Rest of the Middle East & Africa
- GCC
- North America Dengue Vaccine Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
For more information about this report- https://store.rationalstat.com/store/global-dengue-vaccine-market
Key Questions Answered in the Dengue Vaccine Report:
- What will be the market value of the global Dengue Vaccine market by 2030?
- What is the market size of the global Dengue Vaccine market?
- What are the market drivers of the global Dengue Vaccine market?
- What are the key trends in the global Dengue Vaccine market?
- Which is the leading region in the global Dengue Vaccine market?
- What are the major companies operating in the global Dengue Vaccine market?
- What are the market shares by key segments in the global Dengue Vaccine market?
Running a year End discount of 20%-https://store.rationalstat.com/store/global-dengue-vaccine-market/#tab-ux_global_tab
Explore Our Trending Reports
- Global RWE Oncology Market- Global RWE oncology market is expected to grow at a CAGR of around 13.2% during the forecast period of 2023-2030 and is estimated at US$ 720 million in 2023.
- Global Computed Radiography Market- Global computed radiography market is expected to grow at a CAGR of around 5.4% during the forecast period of 2023-2030 and is estimated at US$ 4.3 billion in 2023.
- Nigeria OTC Medications Market- Nigeria OTC medications market is expected to grow at a CAGR of around 13% during the forecast period of 2023-2028 and was valued at around US$ 2.2 billion in 2022.
- Global Sexually Transmitted Diseases Testing Market- Global sexually transmitted diseases testing market is expected to grow at a CAGR of around 7.6% during the forecast period of 2023-2028 and was valued at around US$ 8.5 billion in 2022.
- Global Human Microbiome Market- Global human microbiome market is expected to grow at a CAGR of around 18% during the forecast period of 2023-2030 and is estimated at US$ 650 million in 2023.
- Global Human Microbiome Market- Global human microbiome market is expected to grow at a CAGR of around 18% during the forecast period of 2023-2030 and is estimated at US$ 650 million in 2023.
- Global Swab Market- Global Swab Market is expected to grow at a CAGR of 6.6% over the forecast period of 2022-2028
- Global Pet CBD (cannabidiol) Market- Global Pet CBD (cannabidiol) Market is expected to grow at a CAGR of 12.0% over the forecast period of 2022-2028
- Global Medical Rehabilitation Service Market- Global Medical Rehabilitation Service Market is expected to grow at a CAGR of 6.1% over the forecast period of 2022-2028
- Global Hepatitis B Virus Market- Global Hepatitis B Virus Market is expected to grow at a CAGR of 5.8% over the forecast period of 2022-2028
- Global Hepatitis B Vaccine (Recombinant) Market- Global Hepatitis B Vaccine (Recombinant) Market is expected to grow at a CAGR of 5.6% over the forecast period of 2022-2028
- Global Benign Prostatic Hyperpl Medication Market- Global Benign Prostatic Hyperpl Medication Market is expected to grow at a CAGR of 5.0% over the forecast period of 2022-2028
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Download Key Insights and Market Data - Raise a Query
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
Contact
RationalStat LLC
Kimberly Shaw,
Content and Press Manager
US Phone: +1 302 803 5429
UK Phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | Pinterest
